| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2863922 | The American Journal of the Medical Sciences | 2011 | 4 Pages |
Abstract
Patients who have larger tumor size, liver cirrhosis and higher preoperative aspartate aminotransferase level should be carefully followed up because they are at high risk of HCC recurrence postoperatively.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shih-Wei MD, Kuan-Fu MD, Chung-Yi MD, Chi-Hung MD, Yi-Ying MD,